Listing & Compliance Notices

INVO Fertility, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 11, 2023, the Company received a notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s non-compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”), as of July 10, 2023, the Nasdaq Hearing Panel (the “Panel”) will consider such non-compliance in its decision regarding the Company’s continued listing on Nasdaq. The Company plans to timely submit to the Panel confirmation of its plan to regain compliance under the Rule, providing similar information to that present”

AMERICAN REBEL HOLDINGS INC received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“July 12, 2023, a written notification from the Staff indicating that, as of July 11, 2023, the Company had regained compliance with the Minimum Bid Price Requirement. Once that written notification is received, the Company will not need to appeal the Staff’s delisting determination and the Company’s securities will remain listed for trading on Nasdaq. The Company will issue a press release following receipt of this written notification. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the u”

Singularity Future Technology Ltd. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a), 5810(c)(2)(G)).

“July 7, 2023, Singularity Future Technology Ltd. (the “Company” or “Registrant”) received an Notice of Noncompliance Letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rules due to its failure to timely hold an annual meeting of shareholders for the fiscal year ended June 30, 2022 (the “Annual Meeting”), which is required to be held within twelve months of the Company’s fiscal year end under Nasdaq Listing Rule 5620(a) and 5810(c)(2)(G). The Letter also states that the Company has 45 calendar days to submit a pla”

SONIC FOUNDRY INC received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)).

“July 6, 2023, the Company was notified by Nasdaq that it had not regained compliance with the Rule and is not eligible for a second 180 day period. Additionally, on February 14, 2023, the Staff notified the Company that it failed to comply with Nasdaq’s $2,500,000 minimum stockholders’ equity requirement for continued listing and, as of that date, the Company did not meet the alternative requirements of market value of listed securities or net income from continuing operations as set forth in Listing Rule 5550(b). In that regard, the Company submitted its plan to regain compliance and was gran”

SONIC FOUNDRY INC received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 6, 2023, the Company was notified by Nasdaq that it had not regained compliance with the Rule and is not eligible for a second 180 day period. Additionally, on February 14, 2023, the Staff notified the Company that it failed to comply with Nasdaq’s $2,500,000 minimum stockholders’ equity requirement for continued listing and, as of that date, the Company did not meet the alternative requirements of market value of listed securities or net income from continuing operations as set forth in Listing Rule 5550(b). In that regard, the Company submitted its plan to regain compliance and was gran”

Airspan Networks Holdings Inc. received a nyse_american deficiency notice notice regarding minimum bid price (rules 1003(f)(v)).

“July 10, 2023, Airspan Networks Holdings Inc. (the “Company”) received written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that it is not in compliance with the continued listing standard set forth in Section 1003(f)(v) of the NYSE American Company Guide (the “Company Guide”) because the Company’s common stock was selling for a substantial period of time at a low price per share, which NYSE American determined to be a 30-trading day average of less than $0.20 per share. The Notice stated that the Company’s continued listing is predicated on it effecting a rev”

Next Technology Holding Inc. received a nasdaq extension granted notice regarding late filing (rules 5250(c)(1), 5810(3)(A)(iii)).

“July 6, 2023, the Company received a letter from the Listing Qualifications Department of the Nasdaq notifying the Company that Nasdaq has granted the Company’s request to continue its listing on Nasdaq, subject to the condition that 1). on or before July 14, 2023, the Company shall file the delinquent Form 10-K for the fiscal year ended December 31, 2022, with the SEC; 2). on or before July 31, the Company shall file the delinquent Form 10-Q for the period ended March 31, 2023, with the SEC. The Nasdaq Listing and Hearing Review Council may, on its own motion, determine to review any Panel de”

Doma Holdings, Inc. received a nyse delisting notice notice regarding other (rules 802.01D).

“July 11, 2023, the NYSE provided written notice to the Company, and publicly announced, that the NYSE has determined to commence proceedings to delist the Warrants from the NYSE and that trading in the Warrants would be suspended immediately due to “abnormally low” trading price levels pursuant to Section 802.01D of the NYSE Listed Company Manual. The Company does not intend to appeal the NYSE’s determination. Trading in the Company’s Common Stock is unaffected by this action and will continue on the NYSE under the symbol "DOMA". Cautionary Note Regarding Forward-Looking Statements This Curren”

Toughbuilt Industries, Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“July 7, 2023, ToughBuilt Industries, Inc. (the “ Company ”) received written notice from The Nasdaq Stock Market LLC (“ Nasdaq ”) stating that the Company failed to maintain a minimum bid price of at least $1.00 per share for the prior 30 consecutive trading day period from May 23, 2023 to July 6, 2023, based upon the closing bid price for its common stock as required by Nasdaq Listing Rule 5550(a)(2). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until January 3, 2024, to regain compliance with the minimum bid requirement under Nasdaq Listing Rule 5550(a”

AMERICAN REBEL HOLDINGS INC received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“July 11, 2023, the Registrant received a written notification from the Staff indicating that, as of July 11, 2023, the Company had regained compliance with the Minimum Bid Price Requirement. As a result, the Company will not need to appeal the Staff’s delisting determination and the Company’s securities will remain listed for trading on Nasdaq. As of the close of trading on July 11, 2023, the closing bid price for the Company’s common stock, par value $0.001 per share, was above $1.00 per share for ten (10) consecutive business days. The Company expects to receive on July 12, 2023, a written n”

AUDDIA INC. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“$2,500,000 in stockholders’ equity for continued listing. In its quarterly report on Form 10-Q for the period ended March 31, 2023, the Company reported stockholders’ equity of $2,095,247, and, as a result, does not currently satisfy Listing Rule 5550(b)(1). The letter also indicated that the Company had a period of 45 calendar days from the date of the Notice, or”

Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“July 7, 2023, Enochian Biosciences Inc. (the “ Company ”) received a deficiency notice from The Nasdaq Stock Market (“ Nasdaq ”) informing the Company that its common stock, par value $0.0001 per share (the “ Common Stock ”), fails to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the Common Stock for the 30 consecutive business days prior to the date of the notice from Nasdaq. Nasdaq’s notice has no immediate effect on the listing of the Common Stock on The Nasdaq Capital”

Accelerate Diagnostics, Inc received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“t (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock had been below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market (the “Capital Market”) pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). At that time, the Company was granted a period of 180 calendar days, or until July 5, 2023, to regain compliance with the Minimum Bid Price Requirement. On July 6, 2023, the Company received a determination letter from the Staff notifying the Company”

Acri Capital Acquisition Corp received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“May 19, 2023, Acri Capital Acquisition Corporation (the “ Company ”) received a letter (the “ Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) that, for 30 consecutive business days, the Market Value of Listed Securities for the Company was below the $50 million minimum MVLS requirement for continued listing on the Nasdaq Global Market (the “Global Market”) under Nasdaq Listing Rule 5450(b)(2)(A). The Letter notes that the Company may be eligible to transfer the listing of its securities to the Nasdaq Capital Market (the “Capital Market”). On May”

bleuacacia ltd received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(2)(A)).

“July 5, 2023, bleuacacia ltd (the “Company”) received written notice from the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with the continued listing requirement to maintain a minimum Market Value of Listed Securities (“MVLS”) of $50,000,000, as set forth in Nasdaq Listing Rule 5450(b)(2)(A). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has a period of 180 calendar days, or until January 2, 2024, to regain compliance with the minimum MVLS requirement. To regain compliance, the Company’s M”

Empery Digital Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 6, 2023, the Company received a letter (the “July 6 Letter”) from the Staff notifying the Company that the minimum closing bid price per share for its common stock was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). The July 6 Letter does not have any immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, o”

Empery Digital Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3)).

“July 5, 2023, Volcon, Inc. (the “Company”) received a letter (the “July 5 Letter”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), which notified the Company that it does not presently comply with Nasdaq’s Listing Rule 5550(b)(2), which requires that the Company maintain a Market Value of Listed Securities (“MVLS”) of $35 million, and that the Company also does not otherwise satisfy the requirements of Listing Rules 5550(b)(1) and 5550(b)(3). The Staff calculates MVLS based upon the most recent Total Shares Outstanding (TSO), mul”

Surface Oncology, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“July 6, 2023, Nasdaq notified the Company that the Transfer was approved, and that, in connection with the Transfer, the Company was eligible for an additional 180 calendar day period, or until January 2, 2024 (the “Extended Compliance Date”), to regain compliance with Rule 5550(a)(2). Effective at the opening of business on July 10, 2023, the Common Stock will be transferred to the Nasdaq Capital Market. The Common Stock will continue to trade under the symbol “SURF.” The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, but with less stringent listi”

ADIAL PHARMACEUTICALS, INC. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“July 7, 2023, Adial Pharmaceuticals, Inc. (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that the Company had been granted an extension up until August 21, 2023 to file a Form 10-Q Report for the period ended June 30, 2023 evidencing compliance with Nasdaq Listing Rule 5550(b)(1) (the “Rule”). On May 19, 2023, the Company had received a letter from Nasdaq stating that the Company was not in compliance with the Rule because the stockholders’ equity of the Company of $1,439,848 as of March 31, 2023, as reported in the Company’s Quarterly Report on Form 10-Q fil”

ADIAL PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“May 19, 2023, the Company had received a letter from Nasdaq stating that the Company was not in compliance with the Rule because the stockholders’ equity of the Company of $1,439,848 as of March 31, 2023, as reported in the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 12, 2023, was below the minimum requirement of $2,500,000. The notification received has no immediate effect on the Company's continued listing on the Nasdaq Capital Market, subject to the Company's compliance with the other continued listing requirements. Pursuant to Nasdaq’s Listing Rules, the Company had 4”

Kernel Group Holdings, Inc. received a nasdaq delisting notice notice regarding other (rules 5620(a), 5810(c)(2)(G)).

“July 7, 2023, the Company received a notice (the “Nasdaq Notice”) from the Listing Qualifications Department of Nasdaq stating that, as of June 29, 2023, the Company had failed to hold the above-referenced annual meeting and therefore was not in compliance with the Rule. As a result, Nasdaq has advised the Company that its securities would be subject to delisting unless the Company timely requests a hearing before an independent Hearings Panel (the “Panel”). Accordingly, the Company intends to timely request a hearing. The hearing request will stay the suspension of the Company’s securities an”

Better World Acquisition Corp. received a nasdaq delisting notice notice regarding other (rules 5620(a), 5810(c)(2)(G)).

“June 30, 2023, the Company received a determination letter from the Staff of the Nasdaq stating that, as of June 29, 2023, the Company had failed to hold the above-referenced annual meeting and therefore was not in compliance with the Rule. As a result, the Staff has advised the Company that its securities would be subject to delisting unless the Company timely requests an appeal of this determination to a hearings panel. The Company does not intend to appeal the Staff’s determination to a hearings panel.”

Motus GI Holdings, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“July 6, 2023, the Company received a letter from the Staff advising the Company that the Staff had determined that the Company did not meet the terms of the extension by July 3, 2023. The Company intends to appeal the Staff’s delisting determination by submitting a hearing request to the Nasdaq Hearings Panel (the “Panel”), which request will automatically stay the delisting of the Company’s securities by the Staff on July 17, 2023 at least until the hearing process concludes. At the Panel hearing, the Company intends to present a detailed plan to regain compliance with Listing Rule 5550(b)(1)”

Aclarion, Inc. received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1)).

“July 5, 2023, the Company received a letter from Nasdaq indicating that the Company was now in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq’s letter indicated that this matter is now closed. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ACLARION, INC. July 7, 2023 By: /s/ John Lorbiecki Name: John Lorbiecki Title: Chief Financial Officer 3”

Staffing 360 Solutions, Inc. received a nasdaq extension granted notice regarding late filing (rules 5250(c)(1)).

“July 5, 2023, the Company received a notice (the “ Notice ”) from the Staff notifying the Company that it has been granted an exception to enable the Company to regain compliance with the Rule pursuant to the following terms: on or before October 16, 2023, the Company must file the Form 10-Q, as required by the Rule. In the event the Company does not satisfy the terms of the exception, the Staff will provide written notification that the Company’s common stock will be delisted. The Notice has no immediate effect on the listing of the Company’s common stock. There can be no assurance that the C”

Bio Green Med Solution, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“July 5, 2023, Cyclacel Pharmaceuticals, Inc. (the “ Company ”) received a letter (the “ Extension Notice ”) from the Listing Qualifications Staff of The Nasdaq Stock Market, LLC (“ Nasdaq ”) notifying the Company that Nasdaq has granted the Company a 180-day extension, or until January 2, 2024 (the “ Extension Period ”), to regain compliance with the requirement for the Company’s common stock, par value $0.001 per share (“ Common Stock ”), to maintain a minimum bid price of $1.00 per share for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “”

VISION SENSING ACQUISITION CORP. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(3)(A)).

“June 29, 2023, Vision Sensing Acquisition Corp., a Delaware corporation (the “ Company ”), received a written notice (the “ MVLS Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that since the Market Value of Listed Securities (“ MVLS ”) of the Company was less than $50 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5450(b)(2)(A), which requires the Company to maintain a Market Value of Listed Securities of at least $50 million. Nasdaq noted that the Compa”

Crescera Capital Acquisition Corp. received a nasdaq delisting notice notice regarding market value (rules 5452, 5452(a)(2)(C)).

“June 30, 2023, Crescera Capital Acquisition Corp. (the “Company”), received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company’s securities (units, ordinary shares, warrants, and rights) would be subject to suspension and delisting from The Nasdaq Global Market at the opening of business on July 11, 2023 due to the Company’s non-compliance with: (i) Nasdaq Listing Rule 5452, which requires acquisition companies listed under alternative Listing Rule 5406 to maintain a minimum average market value of listed securities of”

T3 Defense Inc. received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

“June 27, 2023, Brilliant received a notice from the staff of Nasdaq indicating that the Company’s securities would be subject to suspension and delisting from The Nasdaq Capital Market at the opening of business on July 7, 2023 due to the Company’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. If Brilliant did not request a hearing, Brilliant’s securities would have been suspended from The Nasdaq Capital Market at the opening”

T3 Defense Inc. received a nasdaq delisting notice notice regarding market value (rules IM-5101-2).

“Panel”). Previously, on June 27, 2023, Brilliant received a notice from the staff of Nasdaq indicating that the Company’s securities would be subject to suspension and delisting from The Nasdaq Capital Market at the opening of business on July 7, 2023 due to the Company’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. If Brilliant did not request a hearing, Brilliant’s securities would have been suspended from The Nasdaq Capit”

Tattooed Chef, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).

“July 3, 2023, the Company received written notice (the “Delisting Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Chapter 11 Cases and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, Nasdaq had determined that the Company’s common stock will be delisted from Nasdaq. In the Delisting Notice, Nasdaq referenced the Chapter 11 Cases and associated public interest concerns raised by it, concerns regarding the residual equity interest of the existing listed securities holders and concerns about the Company’s ability to sustain”

NVN Liquidation, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“June 30, 2023, Novan, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with Listing Rule 5550(b)(2), which requires the Company to maintain a minimum market value of listed securities of at least $35 million (the “MVLS Requirement”) for continued listing on the Nasdaq Capital Market. The letter noted that, as of that date, the Company’s market value of listed securities was below $35 million for at least 30 consecutive business days. In accordance with Nasdaq”

Ainos, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).

“July 6, 2023, Ainos, Inc. (the “Company”) received notice from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) advising that Staff has determined that the Company is eligible for an additional 180 calendar day period, or until January 2, 2024, to regain compliance with its minimum bid price requirement pursuant to the Nasdaq Listing Rule 5810(c)(3)(A). The notification has no immediate effect on the listing of the Company's common stock on Nasdaq. The Company has a period of an additional 180 calendar days from the date of notification, whi”

MITEK SYSTEMS INC received a nasdaq noncompliance notice notice regarding late filing.

“August 10, 2023, and a final determination regarding the Company’s listing status. As previously disclosed on June 13, 2023, the Company intended to appeal a determination by the Nasdaq Listing Qualifications Department to delist the Company’s securities due to the Company’s failure to timely file its Annual Report on Form 10-K for the period ended September 30, 2023 and its Quarterly Reports on Form 10-Q for the quarterly periods ended December 31, 2022, and March 31, 2023, with the Securities and Exchange Commission. On June 20, 2023 the Company timely requested a hearing before the Panel an”

Cactus Acquisition Corp. 1 Ltd received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“June 29, 2023, Cactus Acquisition Corp. 1 Ltd., a Cayman Islands exempted company (the “Company”), received a written notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company was not in compliance with Listing Rule 5450(b)(2)(A) (the “MVLS Rule”), which requires the Company to have at least $50 million market value of listed securities (the “MVLS”) for continued listing on the Nasdaq Global Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing”

Integral Acquisition Corp 1 received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“June 28, 2023, Integral Acquisition Corporation 1 (the “Company”) received a deficiency notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $50 million required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “Market Value Standard”).This notification has no immediate effect on the listing or trading of the Company’s securities on The Nasdaq G”

Surrozen, Inc./DE received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“July 5, 2023, Surrozen, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company is eligible for an additional 180 calendar day period, or until January 2, 2024, to regain compliance with the minimum $1.00 bid price per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”). In the letter, Nasdaq noted that the Company’s common stock had not regained compliance with the Minimum Bid Req”

AgileThought, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“June 28, 2023, AgileThought, Inc. (the "Company") received a deficiency letter (the “Bid Price Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s Class A Common Stock, $0.0001 par value per share (the “Common Stock”), had closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The Nasdaq Listing Rules”

Alaunos Therapeutics, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“July 5, 2023, Nasdaq notified the Company that the Transfer was approved, and that, in connection with the Transfer, the Company was eligible for an additional 180 calendar day period, or until January 2, 2024 (the “Extended Compliance Date”), to regain compliance with the Bid Price Requirement. Effective at the opening of business on July 7, 2023, the Common Stock will be transferred to the Nasdaq Capital Market. The Common Stock will continue to trade under the symbol “TCRT.” The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Select Market, but with less”

ATI Physical Therapy, Inc. received a nyse deficiency notice notice regarding market value (rules 802.01B).

“June 28, 2023 written notice, the NYSE advised the Company that it remains subject to the conditions set forth in the NYSE’s November 18, 2022 letter regarding noncompliance with the $1.00 over a 30 trading-day average price standard. The Company believes that it is in the process of regaining such compliance as a result of its previously announced reverse stock split effective June 15, 2023.”

SQZ Biotechnologies Co received a nyse delisting notice notice regarding market value (rules 802.01B).

“July 3, 2023, SQZ Biotechnologies Company (the “Company”) received a written notice from the New York Stock Exchange (“NYSE”) notifying the Company that the NYSE will commence proceedings to delist the Company’s common stock (“Common Stock”) from the NYSE. The NYSE reached this determination pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization of at least $15 million over a consecutive 30-trading day period. The NYSE will apply to”

TREX WIND-DOWN, INC. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii)).

“June 28, 2023, Timber Pharmaceuticals, Inc. (the “ Company ”) received a deficiency letter (the “ Deficiency Letter ”) from the NYSE American LLC (the “ NYSE American ”) indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Sections 1003(a)(i) and (ii) of the NYSE American Company Guide. Section 1003(a)(i) of the NYSE American Company Guide requires a listed company’s stockholders’ equity be at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years. Section”

Adaptive Biotechnologies Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A)).

“June 26, 2023, the Company received a notice from Nasdaq regarding non-compliance with the rule requiring three members to serve on an Audit Committee and confirming the cure period applicable to the Company. The Company is evaluating the appropriate composition of its board committees and fully intends to regain compliance with Rule 5605(c)(2)(A) within the applicable cure period. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Adaptive Biotechnol”

KINETA, INC./DE received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“June 27, 2023, Kineta, Inc. (“Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2) (the “Rule”) because the Company has not maintained a minimum Market Value of Listed Securities (“MVLS”) of at least $35 million for the last 30 consecutive business days. The Notice has no immediate effect on the listing or trading of the Company’s securities. The Company has 180 calendar days from the date of the Notice, or until December 26, 2023, t”

Protagonist Therapeutics, Inc received a nasdaq deficiency notice notice regarding audit committee (rules 5605, 5605(c)(4), 5605(a)(2)).

“June 27, 2023, the Company received a letter from Nasdaq confirming that t he Company is no longer in compliance with Nasdaq’s audit committee composition requirements as set forth in Nasdaq Listing Rule 5605, which requires that the audit committee of a listed company be comprised of at least three “independent directors” (as defined in Nasdaq Listing Rule 5605(a)(2)). Pursuant to Nasdaq Listing Rule 5605(c)(4), the Company intends to rely on the cure period to reestablish compliance with Nasdaq Listing Rule 5605. The cure period is generally defined as until the earlier of the Company’s next”

SYNCHRONOSS TECHNOLOGIES INC received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1)).

“June 29, 2023, the Company received notice (the “Second Notice”) from Nasdaq indicating that the Staff has determined that the Company is eligible for an additional 180-day grace period, or until December 26, 2023 (the “Second Compliance Period”), to regain compliance. The Second Compliance Period was granted in connection with the impending transfer of the listing of the Company’s Common Stock from The Nasdaq Global Select Market to The Nasdaq Capital Market, which we received approval from Nasdaq for on June 29, 2023. This transfer will be effective at the opening of business on July 5, 2023”

MariaDB plc received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“June 28, 2023, MariaDB plc (the “ Company ”) received a notice from the New York Stock Exchange (the “NYSE ”) that, as of June 23, 2023, it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s ordinary shares (the “ Ordinary Shares ”) were less than $1.00 per share over a consecutive 30 trading-day period. The notice has no immediate impact on the listing of the Ordinary Shares on the NYSE, subject to the Company’s compliance with the NYSE’s other continued listing requirement”

Genesis Growth Tech Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5450(b)(1)(B)).

“June 28, 2023, Genesis Growth Tech Acquisition Corp. (the “ Company ”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) stating the Company was not in compliance with Nasdaq Listing Rule 5450(b)(1)(B), as a result of the number of publicly held shares of the Company as reported on the Company’s Form 10-K for the period ended December 31, 2022 (i.e., 101,039 shares), having fallen below the minimum of 1,100,000 publicly held shares required for continued listing. The Nasdaq notification letter has no immediate effect on the li”

Mountain Crest Acquisition Corp. V received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(3)(C)).

“June 27, 2023, Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company’s listed securities failed to maintain a minimum Market Value of Publicly Held Shares (“MVPHS”) of $15,000,000 which is a requirement for continued listing on The Nasdaq Global Market in accordance with Nasdaq Listing Rule 5450(b)(3)(C) (the “MVPHS Requirement”) based upon the Company’s MVPHS for the 30 consecutive business days prior to the date of the Notice. The Notice has no immediate effect on the”

Global Technology Acquisition Corp. I received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“June 28, 2023, Global Technology Acquisition Corp. I, a Cayman Islands exempted company (the “Company” or “GTAC”), received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $50 million required for continued listing on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “Market Value Standard”). The Staff also noted that the Company does n”